Twenty-three (54.8%) cases were functional tumors, including carcinoid syndrome, but there were also rare ones secreting glucagon, growth hormone-releasing hormone (GHRH), and PTH-related protein (PTHrP). The gene discussed is PTHLH; the disease is carcinoid syndrome.